儿童急性淋巴细胞白血病入住儿童重症监护室的临床特征分析

吴飞凤, 毛珏怡, 万伍卿, 文川

中国当代儿科杂志 ›› 2026, Vol. 28 ›› Issue (1) : 70-77.

PDF(769 KB)
HTML
PDF(769 KB)
HTML
中国当代儿科杂志 ›› 2026, Vol. 28 ›› Issue (1) : 70-77. DOI: 10.7499/j.issn.1008-8830.2504183
论著·临床研究

儿童急性淋巴细胞白血病入住儿童重症监护室的临床特征分析

作者信息 +

Clinical characteristics of pediatric patients with acute lymphoblastic leukemia admitted to the pediatric intensive care unit

Author information +
文章历史 +

摘要

目的 分析急性淋巴细胞白血病(acute lymphoblastic leukemia, ALL)患儿入住儿童重症监护室(pediatric intensive care unit, PICU)的危险因素及其在PICU接受生命支持治疗(life-sustaining therapy, LST)的危险因素。 方法 回顾性分析2016年6月—2021年6月中南大学湘雅二医院儿童医学中心收治的ALL患儿的临床资料,根据是否入住PICU分为PICU组和非PICU组,采用多因素logistic回归分析入住PICU的危险因素。采用Kaplan-Meier曲线评估PICU累积入住概率。根据是否接受LST将PICU患儿分为LST组和非LST组,采用多因素logistic回归分析接受LST的危险因素。 结果 共纳入200例ALL患儿,其中42例(21.0%)患儿至少入住过一次PICU,总入住次数为48次。多因素分析显示,诊断时伴高白细胞血症和乳酸脱氢酶>500 U/L是ALL患儿入住PICU的独立危险因素(均P<0.05)。Kaplan-Meier曲线显示T淋巴细胞白血病和高白细胞血症均具有相对较高的累积PICU入院率。C反应蛋白、白蛋白水平及呼吸衰竭与患儿接受LST显著相关(均P<0.05);进一步行多因素logistic回归分析显示呼吸衰竭的PICU患儿接受LST的风险显著升高(OR=13.254,P=0.027)。 结论 诊断时伴高白细胞血症和乳酸脱氢酶>500 U/L的ALL患儿入住PICU的风险较高;呼吸衰竭是PICU内ALL患儿接受LST的独立危险因素。

Abstract

Objective To investigate risk factors for pediatric intensive care unit (PICU) admission among children with acute lymphoblastic leukemia (ALL) and risk factors for receipt of life-sustaining therapy (LST) in the PICU. Methods Clinical data of ALL patients treated at the Children's Medical Center of the Second Xiangya Hospital from June 2016 to June 2021 were retrospectively reviewed. Patients were categorized into PICU and non-PICU groups according to PICU admission. Multivariable logistic regression was applied to identify risk factors for PICU admission. The cumulative probability of PICU admission was estimated using Kaplan-Meier curves. PICU patients were further stratified into LST and non-LST groups according to whether LST was received, and multivariable logistic regression was used to identify risk factors for receiving LST. Results A total of 200 children with ALL were included; 42 (21.0%) were admitted to the PICU at least once, with 48 total admissions. Multivariable logistic regression analysis showed that hyperleukocytosis at diagnosis and lactate dehydrogenase (LDH) >500 U/L were independent risk factors for PICU admission (both P<0.05). Kaplan-Meier curves demonstrated that T-cell ALL and hyperleukocytosis were associated with higher cumulative PICU admission rates. Univariate analysis showed that C-reactive protein, albumin, and respiratory failure were significantly associated with the receipt of LST (all P<0.05). Further multivariable logistic regression analysis revealed that respiratory failure was significantly associated with an increased risk of receiving LST (OR=13.254, P=0.027). Conclusions Children with ALL who have hyperleukocytosis at diagnosis and LDH >500 U/L have a higher risk of PICU admission; respiratory failure is an independent risk factor for receipt of LST among PICU-admitted ALL patients.

关键词

急性淋巴细胞白血病 / 儿童重症监护室 / 危险因素 / 儿童

Key words

Acute lymphoblastic leukemia / Pediatric intensive care unit / Risk factor / Child

引用本文

导出引用
吴飞凤, 毛珏怡, 万伍卿, . 儿童急性淋巴细胞白血病入住儿童重症监护室的临床特征分析[J]. 中国当代儿科杂志. 2026, 28(1): 70-77 https://doi.org/10.7499/j.issn.1008-8830.2504183
Fei-Feng WU, Jue-Yi MAO, Wu-Qing WAN, et al. Clinical characteristics of pediatric patients with acute lymphoblastic leukemia admitted to the pediatric intensive care unit[J]. Chinese Journal of Contemporary Pediatrics. 2026, 28(1): 70-77 https://doi.org/10.7499/j.issn.1008-8830.2504183

参考文献

[1]
杨文钰, 竺晓凡. 中国儿童急性白血病的诊治现状及展望[J]. 中华医学杂志, 2024, 104(27): 2477-2482. DOI: 10.3760/cma.j.cn112137-20231211-01347 .
[2]
Maeng CV, Østgård LSG, Christiansen CF, et al. Changes in intensive care unit admission rates, organ support, and mortality in patients with acute myeloid leukaemia over a 12-year period: a Danish nationwide cohort study[J]. Br J Haematol, 2021, 195(1): 137-140. PMCID: PMC8478792. DOI: 10.1111/bjh.17630 .
[3]
Halpern AB, Culakova E, Walter RB, et al. Association of risk factors, mortality, and care costs of adults with acute myeloid leukemia with admission to the intensive care unit[J]. JAMA Oncol, 2017, 3(3): 374-381. PMCID: PMC5344736. DOI: 10.1001/jamaoncol.2016.4858 .
[4]
Kroschinsky F, Weise M, Illmer T, et al. Outcome and prognostic features of intensive care unit treatment in patients with hematological malignancies[J]. Intensive Care Med, 2002, 28(9): 1294-1300. DOI: 10.1007/s00134-002-1420-5 .
[5]
Ranta S, Broman LM, Abrahamsson J, et al. ICU admission in children with acute lymphoblastic leukemia in Sweden: prevalence, outcome, and risk factors[J]. Pediatr Crit Care Med, 2021, 22(12): 1050-1060. DOI: 10.1097/pcc.0000000000002787 .
[6]
梁佩淇, 高梦, 谢妍, 等. 初诊危重急性髓系白血病的临床特征及预后分析[J]. 中华血液学杂志, 2025, 46(1): 39-44. PMCID: PMC11886432. DOI: 10.3760/cma.j.cn121090-20241211-00561 .
[7]
Caballero M, Faura A, Margarit A, et al. Outcomes for paediatric acute leukaemia patients admitted to the paediatric intensive care unit[J]. Eur J Pediatr, 2022, 181(3): 1037-1045. DOI: 10.1007/s00431-021-04292-9 .
[8]
Mottal N, Issa N, Dumas PY, et al. Reduce mortality and morbidity in acute myeloid leukemia with hyperleukocytosis with early admission in intensive care unit: a retrospective analysis[J]. J Hematol, 2020, 9(4): 109-115. PMCID: PMC7665861. DOI: 10.14740/jh691 .
[9]
中国医师协会儿科医师分会儿童血液肿瘤学组, 中华医学会儿科学分会血液学组, 中华医学会儿科学分会肿瘤学组, 等. 儿童急性髓系白血病诊疗专家共识(2024)[J]. 中华儿科杂志, 2024, 62(10): 909-919. DOI: 10.3760/cma.j.cn112140-20240722-00500 .
[10]
中华医学会血液学分会. 血液专科重症单元危重症患者诊疗和管理中国专家共识(2025年版)[J]. 中华血液学杂志, 2025, 46(1): 9-17. PMCID: PMC11886441. DOI: 10.3760/cma.j.cn121090-20241206-00542 .
[11]
中国抗癌协会小儿肿瘤专业委员会. 儿童肿瘤溶解综合征诊疗指南[J]. 中国实用儿科杂志, 2021, 36(12): 890-896. DOI: 10.19538/j.ek2021120602 .
[12]
Hunger SP, Mullighan CG. Acute lymphoblastic leukemia in children[J]. N Engl J Med, 2015, 373(16): 1541-1552. DOI: 10.1056/NEJMra1400972 .
[13]
Kiehl MG, Beutel G, Böll B, et al. Consensus statement for cancer patients requiring intensive care support[J]. Ann Hematol, 2018, 97(7): 1271-1282. PMCID: PMC5973964. DOI: 10.1007/s00277-018-3312-y .
[14]
Kraguljac AP, Croucher D, Christian M, et al. Outcomes and predictors of mortality for patients with acute leukemia admitted to the intensive care unit[J]. Can Respir J, 2016, 2016: 3027656. PMCID: PMC4944052. DOI: 10.1155/2016/3027656 .
[15]
Slavin SD, Fenech A, Jankowski AL, et al. Outcomes for older adults with acute myeloid leukemia after an intensive care unit admission[J]. Cancer, 2019, 125(21): 3845-3852. PMCID: PMC6788935. DOI: 10.1002/cncr.32397 .
[16]
Thakkar SG, Fu AZ, Sweetenham JW, et al. Survival and predictors of outcome in patients with acute leukemia admitted to the intensive care unit[J]. Cancer, 2008, 112(10): 2233-2240. DOI: 10.1002/cncr.23394 .
[17]
Maeng CV, Christiansen CF, Liu KD, et al. Factors associated with risk and prognosis of intensive care unit admission in patients with acute leukemia: a Danish nationwide cohort study[J]. Leuk Lymphoma, 2022, 63(10): 2290-2300. DOI: 10.1080/10428194.2022.2074984 .
[18]
Faraci M, Bagnasco F, Giardino S, et al. Intensive care unit admission in children with malignant or nonmalignant disease: incidence, outcome, and prognostic factors: a single-center experience[J]. J Pediatr Hematol Oncol, 2014, 36(7): e403-e409. DOI: 10.1097/mph.0000000000000048 .
[19]
O'Connor D, Bate J, Wade R, et al. Infection-related mortality in children with acute lymphoblastic leukemia: an analysis of infectious deaths on UKALL2003[J]. Blood, 2014, 124(7): 1056-1061. DOI: 10.1182/blood-2014-03-560847 .
[20]
Inaba H, Pei D, Wolf J, et al. Infection-related complications during treatment for childhood acute lymphoblastic leukemia[J]. Ann Oncol, 2017, 28(2): 386-392. PMCID: PMC5834143. DOI: 10.1093/annonc/mdw557 .
[21]
Liu CY, Li C. Clinical features and risk factors of severe pneumonia in children with acute lymphoblastic leukemia[J]. Front Pediatr, 2022, 10: 813638. PMCID: PMC9120655. DOI: 10.3389/fped.2022.813638 .
[22]
Torres-Flores J, Espinoza-Zamora R, Garcia-Mendez J, et al. Treatment-related mortality from infectious complications in an acute leukemia clinic[J]. J Hematol, 2020, 9(4): 123-131. PMCID: PMC7665858. DOI: 10.14740/jh751 .
[23]
Ferreyro BL, Scales DC, Wunsch H, et al. Critical illness in patients with hematologic malignancy: a population-based cohort study[J]. Intensive Care Med, 2021, 47(10): 1104-1114. DOI: 10.1007/s00134-021-06502-2 .
[24]
Vijenthira A, Chiu N, Jacobson D, et al. Predictors of intensive care unit admission in patients with hematologic malignancy[J]. Sci Rep, 2020, 10(1): 21145. PMCID: PMC7713054. DOI: 10.1038/s41598-020-78114-7 .
[25]
胡瑜, 郑波. 急性高白细胞性白血病的临床研究进展[J]. 国际输血及血液学杂志, 2019, 42(6): 535-542. DOI: 10.3760/cma.j.issn.1673-419X.2019.06.013 .
[26]
王丹, 邵静波, 李红, 等. 儿童血液系统恶性肿瘤并发肿瘤溶解综合征38例临床特点分析[J]. 临床儿科杂志, 2024, 42(8): 684-690. DOI: 10.12372/jcp.2024.23e0868 .
[27]
顿建新, 崔东艳, 张艾, 等. 儿童急性淋巴细胞白血病并发肿瘤溶解综合征18例临床分析[J]. 现代肿瘤医学, 2023, 31(4): 737-740. DOI: 10.3969/j.issn.1672-4992.2023.04.027 .
[28]
张静静, 金旭婷, 李若寒, 等. ICU住院期间平均血清白蛋白水平和患者预后的相关性分析: 一项多中心回顾性队列研究[J]. 中国急救医学, 2022, 42(6): 476-480. DOI: 10.3969/j.issn.1002-1949.2022.06.003 .
[29]
Wang HJ, Chen W, Wang HZ, et al. Expert Consensus on acute respiratory failure in critically ill cancer patients (2023)[J]. Chin Med Sci J, 2023, 38(3):163-177. DOI: 10.24920/004203 .
[30]
Vigneron C, Charpentier J, Valade S, et al. Patterns of ICU admissions and outcomes in patients with solid malignancies over the revolution of cancer treatment[J].. Ann Intensive Care, 2021, 11(1):182. PMID: 34951668; PMCID:PMC8709803. DOI: 10.1186/s13613-021-00968-5 .
[31]
Fitzgerald JC, Li Y, Fisher BT, et al. Hospital variation in intensive care resource utilization and mortality in newly diagnosed pediatric leukemia[J]. Pediatr Crit Care Med, 2018, 19(6): e312-e320. PMCID: PMC5986594. DOI: 10.1097/pcc.0000000000001525 .
[32]
Butt W, Barker G, Walker C, et al. Outcome of children with hematologic malignancy who are admitted to an intensive care unit[J]. Crit Care Med, 1988, 16(8): 761-764. DOI: 10.1097/00003246-198808000-00005 .
[33]
Wösten-van Asperen RM, van Gestel JPJ, van Grotel M, et al. PICU mortality of children with cancer admitted to pediatric intensive care unit a systematic review and meta-analysis[J]. Crit Rev Oncol Hematol, 2019, 142: 153-163. DOI: 10.1016/j.critrevonc.2019.07.014 .
[34]
Saillard C, Elkaim E, Rey J, et al. Early preemptive ICU admission for newly diagnosed high-risk acute myeloid leukemia patients[J]. Leuk Res, 2018, 68: 29-31. DOI: 10.1016/j.leukres.2018.02.015 .

脚注

所有作者声明无利益冲突。


版权

版权所有 © 2023中国当代儿科杂志
PDF(769 KB)
HTML

Accesses

Citation

Detail

段落导航
相关文章

/